Skip to content
Prudent Biotech
  • BLOG
    HOME
  • SYSTEMATIC
    INVESTING
  • NEWSLETTERS
    • Prudent BIOTECH
    • Prudent SMALL CAP
    • Prudent HEALTHCARE
  • MORE
    • FAQ
    • CONTACT US
  • LOGIN
    • LOGIN – BIOTECH
    • LOGIN – SMALL CAP
  • SIGN UP
    • SIGN UP – BIOTECH
    • RENEWAL – BIOTECH
is_archive

DNA TESTING, Artemis Diana
Healthcare Stocks
Stock Market
May 20, 2025

GeneDx: Strong Fundamentals Intact As
Market Misreads Test Volume Dip

GeneDx delivered strong Q1 2025 results, beating revenue and EPS estimates, and raised full-year guidance.The test volume dip is attributable to seasonality, adverse weather, and one fewer business day, not
by Chandra
Prudent Biotech

© 2024. All Rights Reserved.